DeepMed Research

London Health Sciences Centre

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1875-01-01

Employees: 10K

Market Cap: -

Website: http://www.lhsc.on.ca

Clinical Trials

Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder

Phase 1

Conditions: Urinary Tract Infection

Interventions: Other: Antibiotic
Drug: Probiotic

First Posted Date: 2014-01-24

Last Posted Date: 2021-09-09

Lead Sponsor: London Health Sciences Centre

Target Recruit Count: 36

Registration Number: NCT02044965

Locations: 🇨🇦
London Health Sciences Centre, London, Ontario, Canada

Near-Infrared Spectroscopic (NIRS) Tissue Oxygen Saturation and the Vascular Occlusion Test in Cardiac Surgery Patients

Completed

Conditions: Vascular Occlusion Test

First Posted Date: 2012-10-24

Last Posted Date: 2012-10-26

Lead Sponsor: London Health Sciences Centre

Target Recruit Count: 13

Registration Number: NCT01712750

Locations: 🇨🇦
London Health Sciences Centre, London, Ontario, Canada

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)

Phase 4

Completed

Conditions: Neoplasm
Central Venous Catheter Thrombosis

Interventions: Drug: Rivaroxaban

First Posted Date: 2012-10-17

Last Posted Date: 2016-09-08

Lead Sponsor: London Health Sciences Centre

Target Recruit Count: 70

Registration Number: NCT01708850

Locations: 🇨🇦
London Health Sciences Centre, London, Ontario, Canada

Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?

Phase 2

Completed

Conditions: Cognitive Fatigue

Interventions: Drug: Fampridine SR
Drug: Placebo

First Posted Date: 2012-08-17

Last Posted Date: 2015-09-02

Lead Sponsor: London Health Sciences Centre

Target Recruit Count: 60

Registration Number: NCT01667497

Locations: 🇨🇦
London Health Sciences Center and St. Joseph's Heathcare Center (Parkwood), London, Ontario, Canada

Adderall XR and Processing Speed in Multiple Sclerosis (MS)

Phase 2

Completed

Conditions: Multiple Sclerosis
Cognitive Impairment
Impaired Processing Speed

Interventions: Drug: Placebo
Drug: Adderall XR 10 mg
Drug: Adderall XR 5mg

First Posted Date: 2012-08-17

Last Posted Date: 2015-05-12

Lead Sponsor: London Health Sciences Centre

Target Recruit Count: 70

Registration Number: NCT01667484

Locations: 🇨🇦
London Health Sciences Center and St. Joseph's Heathcare Center (Parkwood), London, Ontario, Canada

Imaging Study of Glioblastomas Treated With Avastin

Not Applicable

Terminated

Conditions: Malignant Gliomas

Interventions: Device: DECT
Device: MR spectroscopy

First Posted Date: 2012-03-09

Last Posted Date: 2014-09-15

Lead Sponsor: London Health Sciences Centre

Target Recruit Count: 3

Registration Number: NCT01549392

Locations: 🇨🇦
London Regional Cancer Centre, London, Ontario, Canada

Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI

Phase 2

Completed

Conditions: Rectal Cancer

Interventions: Radiation: ct and mri scans
Radiation: ct, mri and pet scan
Radiation: ct, mri and pet scans

First Posted Date: 2012-02-02

Last Posted Date: 2014-09-09

Lead Sponsor: London Health Sciences Centre

Target Recruit Count: 30

Registration Number: NCT01525056

Locations: 🇨🇦
London Regional Cancer Program, London, Ontario, Canada

Optic Neuritis Recovery After Oral or IV Corticosteroids

Phase 2

Completed

Conditions: Optic Neuritis

Interventions: Drug: corticosteroids

First Posted Date: 2012-02-01

Last Posted Date: 2015-09-02

Lead Sponsor: London Health Sciences Centre

Target Recruit Count: 51

Registration Number: NCT01524250

Locations: 🇨🇦
London Health Sciences Center, London, Ontario, Canada

The Plasma Large-Volume Exchange RCT

Phase 3

Withdrawn

Conditions: Hemolytic Uremic Syndrome
Purpura, Thrombotic Thrombocytopenic

Interventions: Procedure: Plasma Exchange

First Posted Date: 2011-09-13

Last Posted Date: 2013-04-17

Lead Sponsor: London Health Sciences Centre

Registration Number: NCT01433003

Locations: 🇨🇦
Central Facility, London, Ontario, Canada

Atelectasis After Pulmonary Lobectomy: The Effect Of Air During One-Lung Ventilation (OLV) On Postoperative Atelectasis

Not Applicable

Conditions: Pulmonary Atelectasis

Interventions: Other: One Lung Ventilation

First Posted Date: 2011-02-04

Last Posted Date: 2011-02-04

Lead Sponsor: London Health Sciences Centre

Target Recruit Count: 70

Registration Number: NCT01289691

Locations: 🇨🇦
Victoria Hospital, London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy